Reported 2 days ago
Stifel analyst Daniel Arias has revised Illumina's (ILMN) price target from $160 to $135 while maintaining a Buy rating. The adjustment follows Illumina's positive Q1 performance along with a downward revision of its FY25 guidance, which was slightly worse than expected. However, the earnings per share outlook is stronger due to effective mitigation efforts.
Source: YAHOO